Enfusion Inc. (ENFN), a provider of cloud-based investment management software and services, has reached a new 52-week high, with its stock price climbing to $10.75. The company, with a market capitalization of $1.37 billion, maintains strong financial health with a current ratio of 3.62, indicating robust liquidity management. This milestone reflects a significant uptick in investor confidence, as the company has seen a 6.7% increase in its stock value over the past year, supported by impressive revenue growth of 15.78%. The surge to the 52-week high represents a notable achievement for Enfusion, signaling strong market performance and potentially increased interest from investors looking for robust stocks in the technology sector. InvestingPro analysis reveals 13 additional key insights about Enfusion's performance and valuation metrics, essential for informed investment decisions.
In other recent news, Enfusion Inc. has reported a successful third quarter in 2024. The company saw a 15% increase in year-over-year revenue, reaching $51.2 million, and an adjusted EBITDA of $11.1 million, marking a 21.8% margin. Enfusion's annual recurring revenue surpassed $200 million, a 14% year-over-year increase, and the net dollar retention rate stood at 102%. Among the recent developments, Enfusion signed 38 new clients, bringing the total to 894, and reported an average total value of $229,000, up 5.7% year-over-year. The company also showed revenue growth across all regions, with 17% in the Americas, 22% in EMEA, and 6% in Asia-Pacific. Looking ahead, Enfusion is tightening its full-year revenue guidance to between $202 million and $205 million, with EBITDA guidance at $41 million to $45 million. Management remains confident in achieving its medium-term revenue growth target of 20% to 22% from 2025 to 2027.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.